Ertan Eryilmaz
Vice President, Biologics InduPro
Ertan Eryilmaz, Ph.D., is the Vice President of Biologics at InduPro, leading the Molecular Discovery Engineering and Protein Sciences teams and shaping the company’s therapeutic discovery strategy. He specializes in antibody discovery, protein engineering, and advancing biologics from target identification to IND. Prior to InduPro, he led Biologics at Xilio Therapeutics and held key scientific and leadership roles at Takeda Oncology, Agensys/Astellas, and Boehringer Ingelheim. His work contributed to multiple clinical programs, including PADCEV and several bispecific antibody platforms.
Seminars
Tuesday 9th June 2026
From Proximity Mapping to Therapeutics: Rational Target-Pair Selection With the MINTTM Platform for Bispecific ADCs
9:00 am
- Explore how MINT™ maps cell-surface protein microenvironments using proximity proteomics and machine learning to identify novel, co-localized target pairs for precision therapeutics
- Outline how applying MINT™ enables rational selection of tumor-associated proximity antigens (TAPAs), guiding the design of bispecific ADCs with improved tumor selectivity and reduced offtarget engagement
- Analyze how this proximity-driven framework supports the discovery and optimization of multiple bispecific ADC candidates, providing a systematic path from target-pair identification to preclinical validation
